98407653 - INGENIUS

Information

• Trademark
• 98407653

• Source

• Serial Number

  98407653

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  February 15, 2024
  10 months ago

• Transaction Date

  December 23, 2024
  12 days ago

• Status Date

  December 22, 2024
  13 days ago

• Location Date

  December 22, 2024
  13 days ago

• Status Code

  661

• Current Location

  TMO LAW OFFICE 119

  Employee Name

  FAIRBANKS, RONALD

• Attorney Name

  Alexandra MacKay

  Law Office Assigned Location Code

  N10

• Owners

  • Ingenza Limited

Case File Statements

• GS0401: Custom manufacture of biopharmaceuticals for others; biomanufacturing for others, namely, manufacturing of pharmaceuticals, specialty chemicals, bulk chemicals, fine chemicals, cleaning products, household goods, personal care products, sanitary products, foodstuffs, industrial polymer intermediates, fuels or cosmetics using biological organisms in the manufacturing process; manufacturing of biotechnology therapy apparatus for others; processing of chemical reagents; custom manufacture of pharmaceuticals, medicines, cell therapies and gene therapies for others; custom manufacture of cell culture products for others; purification of pharmaceuticals by chemical methods; purification of industrial products by chemical methods; purification of specialty chemicals, bulk chemicals, fine chemicals, cleaning products, household goods, personal care products, sanitary products, foodstuffs, industrial polymer intermediates, fuels and cosmetics by chemical methods; consultancy, information and advisory services relating to all of the aforesaid services
• GS0051: Anti-bacterial preparations for medical purposes; antibiotic preparations; chemicals having antimicrobial properties for medical uses; antibodies for medical purposes; nucleic acids for medical purposes; nucleic recombinant acids for medical purposes; diagnostic preparations and reagents for medical purposes; antibody reagents used for the detection of antigens in cells and tissue for medical purposes; bacteria cultures; bactericides; diagnostic biomarkers for use in assessment of toxicological properties of chemical compounds and mixtures for medical use; cultures of microorganisms for medical purposes; enzymes for medical purposes; enzyme stabilizers for medical purposes; proteins for medical or veterinary purposes; yeasts for medical purposes; bacterial preparations for medical purposes; bactericides for medical purposes; bacterial membranes for medical purposes; biochemical preparations for medical use for the treatment or diagnosis of cardiovascular, infectious, oncological and neurological diseases; biological activators for medical purposes; biological preparations for medical purposes for the treatment or diagnosis of cardiovascular, infectious oncological and neurological diseases; biological preparations for use in cell cultures for medical purposes; biological tissue for medical purposes and cell cultures; diagnostic biomarkers for use in assessment of genomic analysis for medical use; biopharmaceuticals for the treatment or diagnosis of cardiovascular, haematological, infectious, oncological and neurological diseases; biotechnological preparations for medical use; solutions for medical and clinical use in storing and treating cells, blood and blood components; cell culture reagents for medical purposes; cell growth media for growing cells for medical or clinical purposes; cells for medical use; cellular function activating agents for medical purposes; chemical and enzyme preparations for medical or veterinary purposes; chemical reagents for use in biotechnology, genetic research or molecular biology; chemical stabilisers for pharmaceuticals and therapeutics; chemicals for use in molecular separation processes for medical purposes; chemicals for use in multiplying nucleic acid amounts for medical purposes; cultures of microorganisms for medical purposes; cultures of microorganisms for medical use; diagnostic reagents and assay components for clinical, medical and medical laboratory use; diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing for medical purposes; formulations for cryopreservation, namely freezing agents for medical purposes; diagnostic test kits comprised of medical diagnostic biomarkers that test for the presence of genetic markers; growth promoters or stimulants for medical use; immunoassay reagents for medical use; immunomodulators; immunostimulants; immunotherapeutic agents for bacterial infections; in vitro diagnostic preparations for medical use; in vivo diagnostic scanning agents for medical use; indicators for medical diagnosis, namely, biological indicators for the efficacy of vaccines; living cells for medical use; media for bacteriological cultures for medical or veterinary purposes; media for cell culture for use in the biotechnological industry for medical or veterinary purposes; nucleic recombinant acids for medical purposes; nutritive agents for processing living cells for medical purposes; pharmaceutical preparations for activating cellular function for medical purposes; pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment or diagnosis of cardiovascular, haematological, infectious, oncological and neurological conditions; pharmaceutical preparations in the fields of microorganisms and cells for the treatment of cardiovascular, haematological, infectious, oncological and neurological conditions; pharmaceutical, medical or veterinary preparations and substances for the treatment of cardiovascular, haematological, infectious, oncological and neurological conditions; preparations for detecting genetic predispositions for medical purposes; preparations for detecting mutation in prion genes for medical purposes; protein arrays for medical diagnostic and therapeutic uses; reactants for medical diagnosis; reagents and diagnostic substances for use in testing for medical and veterinary purposes; reagents for in-vitro laboratory use, genetic testing or microbiological analysis for medical purposes; reconstituted cells for medical treatments; RNA silencers, namely, preparations that provide RNA interference and gene regulating mechanisms for medical purposes; stem cells for medical purposes; substances in the nature of medical diagnostic reagents for use in genetic probe assay kits for medical use; test assays for medical purposes relating to cell potency, cell identity, cell purity, cell stability, cell sterility and cell viability; therapeutic formulations containing stem cells for the treatment of cardiovascular, haematological, infectious, oncological and neurological conditions; vaccines; biostatic antimicrobial preparations for treating bacteria, mold, mildew, algae and yeast and for inhibiting growth of those organisms; chemicals for separating and culturing of cells for medical or veterinary purposes; gene therapy products, namely, genetically engineered tissues for transplant purposes; microbiological cultures for medical purposes; chemical preparations for use in dna analysis for medical or clinical purposes; chemical reagents and substances for medical research purposes; chemical preparations for medical purposes, namely preparations for the prevention or treatment of cardiovascular, haematological, infectious, oncological and neurological conditions; biochemical preparations and products for use in medicine; antimicrobial preservatives for pharmaceuticals; contrast agents for use in molecular imaging
• PM0001: IN GENIUS
• GS0011: Chemical preparations for biomanufacturing; biochemical preparations for industrial and scientific purposes; chemicals and biochemicals, namely, bulk chemicals in the nature of amines, alcohols, terpenes and polymer intermediates; chemicals and biochemicals, namely, specialty chemicals in the nature of agrichemicals, flavors and fragrances and cosmetic additives; chemicals and biochemicals, namely, fine chemicals in the nature of alkaloids, steroids and chiral pharmaceutical intermediates; chemicals and biochemicals, namely, polymer intermediates in the nature of alkenes, alkanoates and methacrylates; chemicals and biochemicals, namely enzyme stabilisers and surfactants for industrial and scientific purposes; cell growth media for growing cells for scientific use; cells for scientific, laboratory or research purposes; cell culture reagents for scientific and research use; biological tissue and cell cultures for industrial and scientific purposes; chemical diagnostic reagents for industrial purposes; stem cells for research purposes; stem cells for industrial purposes; stem cells for scientific purposes; chemicals for separating and cultivating cells, other than for medical or veterinary purposes; biological preparations for use in cell cultures other than for medical or veterinary use; media for cell culture for use in the biotechnological industry other than for medical or veterinary purposes; reagents for scientific and research use; reconstituted cells for the efficiency or tolerance testing of pharmaceutical products; reconstituted cells for the efficiency or tolerance testing of chemical products; reagents for research purposes; bacteria for research purposes; diagnostic predictive biomarker assay and reagents for scientific or industrial purposes; cultures of microorganisms, other than for medical and veterinary use; cell culture media for microbiology research; enzymes for industrial and research purposes; enzyme stabilizers; proteins for use in manufacture; raw proteins for scientific and medical research; yeast for scientific or industrial purposes; monoclonal antibodies for scientific purposes; nucleic acids for scientific purposes; nucleic recombinant acids for scientific purposes; diagnostic preparations and reagents for scientific or research use; chemicals for use in science; chemicals for use in biotechnological manufacturing processes or product development; chemicals for use in molecular separation processes, other than for medical or veterinary purposes; chemicals for use in performing nucleic acid polymerase chain reactions, other than for medical and veterinary purposes; chemicals having antimicrobial properties, other than for medical or veterinary purposes; test kits comprising peptide substrates used in analyzing and detecting certain toxins for scientific or research use; substances in the nature of nucleotides, peptides and enzymes for use in genetic probe assay kits, not for medical or veterinary use; diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria other than for medical or veterinary purposes; reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields other than for medical or veterinary purposes; chemical preparations for use in dna analysis; bacterial preparations for scientific or industrial use; bacterial cultures for industrial purposes; bacterial preparations for research purposes; reagents for medical research; diagnostic reagents, except for medical or veterinary use; chemical reagents for use in biotechnology, other than for medical or veterinary use; chemical reagents for molecular biology, other than for medical or veterinary use; chemical reagents for use in genetic research; biological preparations for use in cell cultures, cell therapy or gene therapy other than for medical or veterinary purposes; biological preparations for use in science; biological activators namely, biostimulants used for research purposes; growth stimulants for biomanufacturing and research purposes other than for medical or veterinary use; preservatives for pharmaceutical preparations; preservatives for maintaining the viability of micro-organisms in cultures; nutritive agents for processing living cells, other than for medical or veterinary use; temperature stabilisers in the nature of polymer additives for industrial manufacture; low molecular weight polythene terpolymers for use in industry; biochemical reagents for industrial, scientific or research purposes; accelerators for speeding up chemical reactions; cultures of microorganisms for industrial purposes; purification preparations and chemicals for use in purification of proteins, peptides, and primary or secondary metabolites; biomaterials in the nature of biological tissue cells for medical research purposes
• GS0441: Genetic testing services for medical purposes; medical and health screening services relating to DNA, genetics and genetic testing; blood testing services being medical analysis services for diagnostic and treatment purposes by medical laboratories; medical health screening services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical laboratory services for the analysis of blood samples for diagnostic and treatment services; medical diagnostic services; DNA screening for medical or veterinary purposes; sequencing of microbiome and DNA in humans for medical purposes; analysis of human serum for medical treatment; analysis of human serum or human tissues for medical treatment; analysis of human tissues for medical treatment; medical and healthcare services; medical examinations; health assessment surveys; health consultancy; remote monitoring of medical data for medical diagnosis and treatment; preparation of reports relating to medical matters; providing health information via a website; gene bank services; medical treatment using cultured cells; consultancy, information and advisory services relating to all of the aforesaid services
• GS0421: Genetic engineering services; genetic mapping for scientific purposes; research relating to genetics and genetic engineering; structural and functional analysis of genomes; scientific research in the field of molecular genetics; scientific and technological services, namely research in the field of biotechnology; research and product development services in the fields of biotechnology and genetics; biochemical research and development; research relating to molecular sciences; contract research services relating to molecular sciences; analysis in the field of molecular biology; research services in the field of proteins, antibodies, microorganisms and cells; microbiological testing; research and development services in the field of biopharmaceuticals; research and development in the field of microorganisms and cells; research, development, analysis and evaluation services in connection with biotechnology, pharmaceuticals, diagnostic preparations, vaccines, medicine, health, microorganisms, molecular sciences, bacteria, biochemicals, cells, stem cells, clinical trials, physiology, genetics, genomics, microbiome, metabolomics, proteomics, glycomics, biochemistry and therapeutics; scientific and medical research services in the field of modulating therapeutics; biological, biomedical and pharmacological research, analysis and development services; research and development of biological drug delivery platforms; research and development of compounds for use in targeted pharmaceutical therapies; research relating to molecular sciences and biotechnology; scientific laboratory services; laboratory analysis and research in the fields of bacteriology, gene expression or molecular biology; services of a chemical and/or biological laboratory; DNA sequencing technology research; DNA screening for scientific research purposes; culturing of cells for scientific or medical research purposes; culturing of cells for others for scientific or medical research purposes; testing of human tissues and stem cells for scientific or medical research purposes; testing and analysis of blood plasma, red blood cells, white blood cells, blood platelets for scientific research purposes; cell programming services, namely genomic engineering services; scientific services relating to the isolation and cultivation of human tissues and cells; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; analytical services, namely, analysis relating to the determination of the bacterial content of liquids; custom design and development of chemical reagents and biochemical assays; custom development of biochemical reagents; development of industrial processes; development and application of culture methods for others of microbes, bacteria, yeast, fungi and mammalian cells; development of means for others to recover and purify products, including pharmaceutical and industrial products, from cultured cells and culture media; cell culture services for scientific and research purposes for others; development and testing of culture methods; development and implementation of recovery methods for others from cultured cells and culture media, for scientific, pharmaceutical or industrial purposes; cell purification services; cell separation services; development of testing methods in the field of biopharmaceuticals; providing reagent sample diagnostic and testing services for others for scientific research purposes; engineering services; pharmaceutical drug development services; biotechnology and chemical testing; microbiological testing; analysis and evaluation services in connection with substances for use in fields dealing with biotechnology, microorganisms, cells, pharmaceuticals, medicine, molecular sciences, bacteria, physiology, biology, genetics, genomics, metagenomics, microbiome, metabolomics, proteomics, glycomics and biochemistry; industrial analysis and research services in the field of biomanufacturing; analysis, management and review of technical data for research purposes in the field of medical sciences; providing evaluations of the efficacy of new pharmaceuticals and preparation of related technical reports; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical product evaluation; preparation of reports in the field of biotechnology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; technical testing, measuring, survey and evaluation services in the field of medical biotechnology; testing of pharmaceuticals; testing, authentication and quality control in the field of biologics; software engineering; design, development and maintenance of software in the field of biotechnology; providing non-downloadable software for controlling, monitoring, programming and adjusting environmental conditions for cell culture, cell therapy or gene therapy; providing non-downloadable software for monitoring patient health; research, design and development services in biotechnology; design and development of scientific cell culture, cell therapy or gene therapy equipment and apparatus; development of systems and manufacturing processes for others in the field of biotechnology; consultancy, information and advisory services relating to all of the aforesaid services

Case File Event Statements

• 2/15/2024 - 10 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 2/26/2024 - 10 months ago

  2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 6/19/2024 - 6 months ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/9/2024 - 3 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 10/7/2024 - 2 months ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/7/2024 - 2 months ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/22/2024 - 13 days ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/22/2024 - 13 days ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/22/2024 - 13 days ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/7/2024 - 2 months ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT